Effect of aspirin desensitization on T-cell cytokines and plasma lipoxins in aspirin-exacerbated respiratory disease

Allergy and Asthma Proceedings

Volumn 35, Issue 2, 2014, Pages 148-155

  Aksu, Kurtuluş ^a   Kurt, Emel ^a   Alatas, Özkan ^a   Gülbas, Zafer ^a  

^a ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

15 EPI LIPOXIN A4; ACETYLSALICYLIC ACID; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 5; LIPOXIN; LIPOXIN A; PLACEBO; UNCLASSIFIED DRUG; CYTOKINE;

ADULT; ARTICLE; ASPIRIN EXACERBATED RESPIRATORY DISEASE; ASTHMA; BLOOD LEVEL; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DESENSITIZATION; DISEASE CONTROL; DRUG EFFECT; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; MEASUREMENT; MIDDLE AGED; PRICK TEST; PROTEIN EXPRESSION; PROVOCATION TEST; SPIROMETRY; T LYMPHOCYTE; BLOOD; CASE CONTROL STUDY; DRUG HYPERSENSITIVITY; IMMUNOLOGY; METABOLISM; RESPIRATORY HYPERSENSITIVITY; T LYMPHOCYTE SUBPOPULATION; TREATMENT OUTCOME;

ADULT; ASPIRIN; CASE-CONTROL STUDIES; CYTOKINES; DESENSITIZATION, IMMUNOLOGIC; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; LIPOXINS; MALE; MIDDLE AGED; RESPIRATORY HYPERSENSITIVITY; T-LYMPHOCYTE SUBSETS; TREATMENT OUTCOME;

EID: 84897071437     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2014.35.3726     Document Type: Article

References (30)

1. Szczeklik A, and Stevenson D. Aspirin induced asthma: Advances in pathogenesis and management. J Allergy Clin Immunol 104:5-13, 1999. (Pubitemid 29364472)
2. Lee RU, and Stevenson DD. Aspirin-exacerbated respiratory disease: Evaluation and management. Allergy Asthma Immunol Res 3:3-10, 2011.
3. Sladek K, Dworski R, Soja J, et al. Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge. Am J Respir Crit Care Med 149:940-946, 1994. (Pubitemid 24108486)
4. Bochenek G, Nagraba K, Nizankowska E, and Szczeklik A. A controlled study of 9alpha,11beta-PGF2 (a prostaglandin D2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge. J Allergy Clin Immunol 111:743-749, 2003. (Pubitemid 36470243)
5. Cowburn AS, Sladek K, Soja J, A et al. Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Clin Invest 101:834-846, 1998. (Pubitemid 28096081)
6. Sanak M, Levy BD, Clish CB, et al. Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics. Eur Respir J 16:44-49, 2000. (Pubitemid 30480126)
7. Schäfer D, Schmid M, Göde UC, and Baenkler HW. Dynamics of eicosanoids in peripheral blood cells during bronchial provocation in aspirin-intolerant asthmatics. Eur Respir J 13:638-646, 1999. (Pubitemid 29180179)
8. Global Initiative for Asthma. Global strategy for asthma management and prevention. Updated 2009. Available online at www.ginasthma.org; accessed February 11, 2010.
9. Fokkens WJ, Lund VJ, Mullol J, et al. European position paper on rhinosinusitis and nasal polyps 2012. Rhinol Suppl 23:231-299, 2012.
10. Chang JE, Chin W, and Simon R. Aspirin-sensitive asthma and upper airway diseases. Am J Rhinol Allergy 26:27-30, 2012.
11. Chang JE, White A, Simon RA, and Stevenson DD. Aspirin-exacerbated respiratory disease: Burden of disease. Allergy Asthma Proc 33:117-121, 2012.
12. Stevenson DD, Hankammer MA, Mathison DA, et al. Aspirin desensitization treatment of aspirin-sensitive patients with rhinosinusitis-asthma: Long-term outcomes. J Allergy Clin Immunol 98:751-758, 1996. (Pubitemid 26357241)
13. Shome GP, Tarbox J, Shearer M, and Kennedy R. Cytokine expression in peripheral blood lymphocytes before and after aspirin desensitization in aspirin-exacerbated respiratory disease. Allergy Asthma Proc 28:706-710, 2007.
14. Berges-Gimeno MP, Simon RA, and Stevenson DD. Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 111:180-186, 2003. (Pubitemid 36143311)
15. Rondón C, Romero JJ, López S, et al. Local IgE production and positive nasal provocation test in patients with persistent nonallergic rhinitis. J Allergy Clin Immunol 119:899-905, 2007. (Pubitemid 46527823)
16. Proceedings of the ATS workshop on refractory asthma: Current understanding, recommendations, and unanswered questions. American Thoracic Society. Am J Respir Crit Care Med 162:2341-2351, 2000.
17. Daffern PJ, Muilenburg D, Hugli TE, and Stevenson DD. Association of urinary leukotriene E4 excretion during aspirin challenges with severity of respiratory responses. J Allergy Clin Immunol 104:559-564, 1999. (Pubitemid 29451644)
18. Christie PE, Spur BW, and Lee TH. The effects of lipoxin A4 on airway responses in asthmatic subjects. Am Rev Respir Dis 145:1281-1284, 1992.
19. Sestini P, Armetti L, Gambaro G, et al. Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma. Am J Respir Crit Care Med 153:572-575, 1996. (Pubitemid 26051332)
20. Borish L, and Rosenwasser LJ. Cytokines in allergic inflammation. In Middleton's Allergy: Principles and Practice, 7th ed. Adkinson NF Jr, Bochner BS, Busse WW, et al. (Eds). New York, NY: Mosby, 165-180, 2009.
21. Peebles RS Jr, and Boyce JA. Lipid mediators of hypersensitivity and inflammation. In Middleton's Allergy: Principles and Practice, 7th ed. Adkinson NF Jr, Bochner BS, Busse WW, et al. (Eds). New York, NY: Mosby, 203-221, 2009.
22. Steinke JW, Liu L, Huyett P, et al. Prominent role of IFN-γ in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 132:856-865.e1-3, 2013. (DOI: 10.1016/j.jaci.2013.05.008. Epub ahead of print June 24, 2013.)
23. Kim SH, Yang EM, Lee HN, et al. Combined effect of IL-10 and TGF-beta1 promoter polymorphisms as a risk factor for aspirin-intolerant asthma and rhinosinusitis. Allergy 64:1221-1225, 2009.
24. Carpagnano GE, Resta O, Gelardi M, et al. Exhaled inflammatory markers in aspirin-induced asthma syndrome. Am J Rhinol 21:542-547, 2007. (Pubitemid 350099762)
25. Katial RK, Strand M, Prasertsuntarasai T, et al. The effect of aspirin desensitization on novel biomarkers in aspirin-exacerbated respiratory diseases. J Allergy Clin Immunol 126:738-744, 2010.
26. Levy BD, Bonnans C, Silverman ES, et al. Severe Asthma Research Program, National Heart, Lung, and Blood Institute. Diminished lipoxin biosynthesis in severe asthma. Am J Respir Crit Care Med 172:824-830, 2005.
27. Vachier I, Bonnans C, Chavis C, et al. Severe asthma is associated with a loss of LX4, an endogenous anti-inflammatory compound. J Allergy Clin Immunol 115:55-60, 2005. (Pubitemid 40075421)
28. Levy BD, De Sanctis GT, Devchand PR, et al. Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4). Nat Med 8:1018-1023, 2002. (Pubitemid 35033707)
29. Planagumà A, Kazani S, Marigowda G, et al. Airway lipoxin A4 generation and lipoxin A4 receptor expression are decreased in severe asthma. Am J Respir Crit Care Med 178: 574-582, 2008.
30. Menzies D, Nair A, Meldrum KT, et al. Effect of aspirin on airway inflammation and pulmonary function in patients with persistent asthma. J Allergy Clin Immunol 121:1184-1189.e4, 2008.